Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells. 2014

Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina , 715 Sumter Street, Columbia, South Carolina 29208, United States.

Ideal "smart" nanoparticles for drug delivery should enhance therapeutic efficacy without introducing side effects. To achieve that, we developed a drug delivery system (HCN) based on a polymer-drug conjugate of poly[2-(pyridin-2-yldisulfanyl)]-graft-poly(ethylene glycol) and camptothecin with an intracellularly cleavable linker and human epidermal growth factor receptor 2 (HER2) targeting ligands. An in vitro drug release study found that HCN was stable in the physiological environment and supersensitive to the stimulus of elevated intracellular redox potential, releasing all payloads in less than 30 min. Furthermore, confocal microscopy revealed that HCN could specifically enter HER2-positive cancer cells. As a consequence, HCN could effectively kill HER2-positive cancer cells while not affecting HER2-negative cells.

UI MeSH Term Description Entries
D007624 KB Cells This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. HeLa-KB Cells,Cell, HeLa-KB,Cell, KB,Cells, HeLa-KB,Cells, KB,HeLa KB Cells,HeLa-KB Cell,KB Cell
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
July 2013, Molecular pharmaceutics,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
January 2017, International journal of nanomedicine,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
November 2019, Nanoscale,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
December 2016, International journal of pharmaceutics,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
January 2019, International journal of nanomedicine,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
July 2016, Cancer gene therapy,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
April 2024, Journal of peptide science : an official publication of the European Peptide Society,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
July 2023, BMC cancer,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
July 2011, Biotechnology and bioengineering,
Bahadur K C Remant, and Varun Chandrashekaran, and Bei Cheng, and Hexin Chen, and Maria Marjorette O Peña, and Jiajia Zhang, and Janis Montgomery, and Peisheng Xu
January 2019, Applied biochemistry and biotechnology,
Copied contents to your clipboard!